Radiopharmaceuticals [radiofarmaka]

topical
808
Terms

Radiopharmaceutical

Persistent link   https://www.medvik.cz/link/D019275
Definition

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

DUI
D019275 MeSH Browser
CUI
M0028704
Previous indexing
specific chemical (1966-1996)
History note
97
Public note
97

Allowable subheadings

AD
administration & dosage 92
AE
adverse effects 52
AN
analysis 17
BL
blood 2
CF
cerebrospinal fluid
CS
chemical synthesis 22
CH
chemistry 42
CL
classification 26
EC
economics 6
HI
history 7
IM
immunology 2
IP
isolation & purification 2
ME
metabolism 20
PK
pharmacokinetics 38
PD
pharmacology 50
PO
poisoning
RE
radiation effects 3
ST
standards 4
SD
supply & distribution 9
TU
therapeutic use 154
TO
toxicity 5
UR
urine 2

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 409
D27.505.259 Diagnostic Uses of Chemicals 6
D27.505.259.500 Contrast Media 1 163
D27.505.259.750 Molecular Probes 47
D27.505.259.812 Neuronal Tract-Tracers
D27.505.259.843 Radiopharmaceuticals 808
D27.505.259.875 Reagent Kits, Diagnostic 260
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.124 Alkylating Agents 91
D27.505.519.143 Amylin Receptor Agonists
D27.505.519.162 Angiotensin Receptor Antagonists 223
D27.505.519.170 Antacids 162
D27.505.519.174 Antidiuretic Hormone Receptor Antagonists 28
D27.505.519.178 Antifoaming Agents 12
D27.505.519.182 Antiglycation Agents
D27.505.519.186 Antimetabolites 120
D27.505.519.217 Antioxidants 2 531
D27.505.519.241 Aversive Agents
D27.505.519.265 Bradykinin Receptor Antagonists 10
D27.505.519.270 Calcitonin Gene-Related Peptide Receptor Antagonists 74
D27.505.519.275 CCR5 Receptor Antagonists 4
D27.505.519.295 Cerumenolytic Agents 1
D27.505.519.334 Cystine Depleting Agents
D27.505.519.349 Cytochrome P-450 Enzyme Inducers 10
D27.505.519.364 Endothelin Receptor Antagonists 121
D27.505.519.374 Enzyme Activators 30
D27.505.519.389 Enzyme Inhibitors 881
D27.505.519.405 Enzyme Reactivators 16
D27.505.519.421 Fibrin Modulating Agents 2
D27.505.519.452 Heparin Antagonists 23
D27.505.519.507 Immune Checkpoint Inhibitors 360
D27.505.519.562 Membrane Transport Modulators 22
D27.505.519.593 Mitosis Modulators 3
D27.505.519.625 Neurotransmitter Agents 517
D27.505.519.656 Nitric Oxide Donors 63
D27.505.519.828 Peptidomimetics 11
D27.505.519.871 Radiopharmaceuticals 808
D27.505.519.914 Sequestering Agents 1
D27.505.519.936 Sodium-Glucose Transporter 2 Inhibitors 794
D27.505.519.947 Sphingosine 1 Phosphate Receptor Modulators 27
D27.505.519.952 Toll-Like Receptor Agonists
D27.505.519.957 Viral Fusion Protein Inhibitors
D27.720 Specialty Uses of Chemicals 56
D27.720.470 Laboratory Chemicals 42
D27.720.470.410 Indicators and Reagents 417
D27.720.470.410.080 Affinity Labels 8
D27.720.470.410.200 Chromogenic Compounds 20
D27.720.470.410.210 Cross-Linking Reagents 125
D27.720.470.410.360 Intercalating Agents 37
D27.720.470.410.505 Luminescent Agents 4
D27.720.470.410.577 Neuronal Tract-Tracers
D27.720.470.410.614 Radioactive Tracers 55
D27.720.470.410.650 Radiopharmaceuticals 808
D27.720.470.410.680 Reagent Kits, Diagnostic 260
D27.720.470.410.690 Reducing Agents 9
D27.720.470.410.700 Sulfhydryl Reagents 13
D27.720.470.410.750 Thiobarbituric Acid Reactive Substances 113

Add